COVID-19 Pandemic’s Effects May Provide ESKD Insights
The COVID-19 supplement of the 2020 US Renal Data System 2020 Annual Data Report provides important insights into dialysis and chronic kidney disease (CKD) during the COVID-19 pandemic.
The COVID-19 supplement of the 2020 US Renal Data System 2020 Annual Data Report provides important insights into dialysis and chronic kidney disease (CKD) during the COVID-19 pandemic.
Older adults with an eGFR of 30 to 59 and less than 30 mL/min/1.73 m2 had a 1.7- and 2.6-fold fold higher risk of dementia, respectively, compared with those who had normal kidney function (eGFR 90-104 mL/min/1.73 m2).
Higher erythropoietin doses may be an independent risk factor for hip fractures in hemodialysis patients, data suggest.
For many health care professionals, successfully managing uncertainty means recognizing that surety is complicated and illusory and knowledge is iterative and provisional rather than definitive.
Androgen deprivation therapy added to radiation therapy (RT) for unfavorable-risk prostate cancer is not associated with an increased risk for cardiovascular mortality compared with RT alone, even among patients with preexisting cardiovascular disease, a study found.
During weeks 12-19 of 2020, the incidence of end-stage kidney disease decreased 20% compared with the same period in 2017-2019, according to a COVID-19 supplement to the US Renal Data System 2020 annual data report.
Each 1 unit increment in Dietary Inflammatory Index was associated with a 4.0% increase in the odds of testosterone deficiency.
About 83% of deaths among men with local or regional prostate cancer are due to other causes, according to a large population-based study.